Developments in oncological positron emission tomography/computed tomography assessment

Journal: J Thorac Dis
Veröffentlichung: 7. Dezember 2015

Implementing amplicon-based next generation sequencing in the diagnosis of small cell lung carcinoma metastases

Journal: Exp Mol Pathol
Veröffentlichung: 6. November 2015

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors.

Journal: Oncologist
Veröffentlichung: 20. Oktober 2015

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort.

Journal: J Thorac Oncol.
published 10th of october, 2015

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.

Journal: Int J. Cancer
Veröffentlichung: 4. September 2015

A Modeling and Simulation Framework for Adverse Events in Erlotinib-Treated Non-Small-Cell Lung Cancer Patients.

Journal: AAPS J.
published: August 19th, 2015

Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.

Journal: Eur J Nucl Med Mol Imaging
published 18th of August, 2015

Comprehensive genomic profiles of small cell lung cancer.

Journal: Nature
Veröffentlichung: 6. August 2015

Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients.

Journal: J Thorac Oncol
Published: July 10th, 2015

A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.

Journal: Cell
published 2nd of july, 2015

Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.

Journal: J Thorac Oncol
Veröffentlichung: 10. Jun. 2015 (Epub 10. Jun. 2015)

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability.

Journal: Oncotarget
Veröffentlichung: 30. Apr. 2015 (Epub 30. Apr. 2015)

Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort.

Journal: J. Clin Oncol
Veröffentlichung: 20. März 2015 (Epub 9. Feb. 2015)

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.

Journal: Lancet Oncol
Veröffentlichung: 16. März 2015 (Epub 20. Feb. 2015 )

Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus.

Journal: Lung Cancer
Veröffentlichung: Feb. 2015 (Epub 18. Dez. 2014 Review)

Modeling tumor dynamics and overall survival in advanced non-small-cell lung cancer treated with erlotinib

Journal: J Thorac Oncol
Veröffentlichung: 10. Jan. 2015 (Epub 10. Jan. 2015)

PD-L1 expression in small cell neuroendocrine carcinomas.

Journal: Eur J Cancer
Veröffentlichung: 9. Jan. 2015

Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data.

Journal: Genome Biol
Veröffentlichung: 5. Jan. 2015